» Articles » PMID: 36278030

The Signal-to-cutoff Ratios to Predict HCV Infection Among People Who Inject Drugs

Overview
Journal Virusdisease
Publisher Springer
Specialty Microbiology
Date 2022 Oct 24
PMID 36278030
Authors
Affiliations
Soon will be listed here.
Abstract

People who inject drugs (PWIDs) are primarily the high-risk population for HCV infection. This study aims to determine the optimal cut-off values for predicting HCV infection status based on the Signal-to-Cutoff (S/CO) ratio. In this study, a total of 719 PWIDs' samples were collected, and performed for screening test by ELISA assay, and followed by RIBA assay and NAT assay to detect HCV antibody and HCV RNA levels, respectively. The findings revealed that the prevalence of HCV infection among PWIDs was 54.66% (393/719), and the false-positive rate of HCV antibody detection by ELISA assay among PWIDs was only 3.85% (16/416). In addition, when the optimal cut-off value for S/CO ratio was 2.0, the sensitivity and specificity of HCV antibody were 100.00% and 93.55%, respectively. And when the optimal cut-off value for S/CO ratio was 21.36, the sensitivity and specificity of HCV RNA positive were 89.90% and 72.73%, respectively. In conclusion, the status of HCV infection can be predicted based on the S/CO ratios of the ELISA assay, which can improve diagnosis and facilitate timely treatment to effectively prevent the spread of HCV infection.

Citing Articles

Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia.

Shawky H, Tabll A, Elshenawy R, Helmy N, Moustafa R, Elesnawy Y Microb Cell Fact. 2024; 23(1):25.

PMID: 38238770 PMC: 10795219. DOI: 10.1186/s12934-024-02297-1.

References
1.
Pan J, Li X, He G, Yuan S, Feng P, Zhang X . Reflex threshold of signal-to-cut-off ratios of the Elecsys anti-HCV II assay for hepatitis C virus infection. J Infect Dev Ctries. 2016; 10(9):1031-1034. DOI: 10.3855/jidc.7301. View

2.
Yi S, Choi J, Yi J, Lee Y, Han K . Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea. Cancer. 2018; 124(13):2748-2757. DOI: 10.1002/cncr.31406. View

3.
Kim B, Ahn H, Choi M, Park Y . Retrospective analysis on the diagnostic performances and signal-to-cut-off ratios of the Elecsys Anti-HCV II assay. J Clin Lab Anal. 2017; 32(1). PMC: 6817162. DOI: 10.1002/jcla.22165. View

4.
Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A . Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002; 155(4):323-31. DOI: 10.1093/aje/155.4.323. View

5.
Alter M, Kuhnert W, Finelli L . Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003; 52(RR-3):1-13, 15; quiz CE1-4. View